| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/02/2009 | EP2124906A1 Polypeptide films and methods |
| 12/02/2009 | EP2124905A2 Vegetarian microcapsules |
| 12/02/2009 | EP2124904A1 Stable sustained release formulations of fluvastatin |
| 12/02/2009 | EP2124903A1 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent |
| 12/02/2009 | EP2124902A2 An improved monolithic drug delivery system |
| 12/02/2009 | EP2124901A1 Tablet preparation without causing a tableting trouble |
| 12/02/2009 | EP2124900A2 Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
| 12/02/2009 | EP2124899A2 Stable pharmaceutical formulations of atorvastatin magnesium salt |
| 12/02/2009 | EP2124898A1 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
| 12/02/2009 | EP2124897A1 Stable anti-nausea oral spray formulations and methods |
| 12/02/2009 | EP2124896A2 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof |
| 12/02/2009 | EP2124894A2 Aqueous formulations |
| 12/02/2009 | EP2124893A1 Pharmaceutical compositions comprising a calcilytic agent |
| 12/02/2009 | EP2124892A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament |
| 12/02/2009 | EP2124891A1 Controlled release preparation containing cilostazoland process for the preparation thereof |
| 12/02/2009 | EP2124890A2 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/02/2009 | EP2124889A2 Protein formulations containing sorbitol |
| 12/02/2009 | EP2124888A2 Sustained delivery formulations of rapamycin compounds |
| 12/02/2009 | EP2124887A2 -lactam-containing formulations having increased stability in aqueous solution |
| 12/02/2009 | EP2124886A2 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 12/02/2009 | EP2124884A2 Compositions comprising bile acid sequestrants for treating esophageal disorders |
| 12/02/2009 | EP2124883A2 Pharmaceutical formulations and methods for making the same |
| 12/02/2009 | EP2124882A2 Anti-inflammatory compounds containing compositions for treatment of cancer |
| 12/02/2009 | EP2124881A1 Ciclesonide containing sterile aqueous suspension |
| 12/02/2009 | EP2124880A2 Fluorescent nanoparticles |
| 12/02/2009 | EP2124879A2 Processes for making cyclic lipid implants for intraocular use |
| 12/02/2009 | EP2124878A1 Increased effectiveness of allylamine drug compounds |
| 12/02/2009 | EP2124640A2 Agent for use in the case of fructose intolerance |
| 12/02/2009 | EP2124606A2 Composition and method of stabilized sensitive ingredient |
| 12/02/2009 | EP2124605A2 Composition and method of stabilized sensitive ingredient |
| 12/02/2009 | EP2124600A1 Medicated chewing gum |
| 12/02/2009 | EP2124552A1 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 12/02/2009 | EP1750673B1 Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof |
| 12/02/2009 | EP1666043B1 Product containing prostaglandin |
| 12/02/2009 | EP1546102B1 Aerosol paint composition for adherence to plastic |
| 12/02/2009 | EP1503763B1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 12/02/2009 | EP1487416B1 Drug microparticles |
| 12/02/2009 | EP1463440B1 Prevention of flap necrosis in plastic surgery |
| 12/02/2009 | EP1435909B1 Stable composition comprising particles in a frozen aqueous matrix |
| 12/02/2009 | EP1414459B1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 12/02/2009 | EP1328386B1 Methods of forming shaped articles from suspensions |
| 12/02/2009 | EP1326500B1 Encased food product with contrasting components |
| 12/02/2009 | EP1313820B1 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/02/2009 | EP1272179B1 Hydrophilic molecular disperse solutions of carvedilol |
| 12/02/2009 | EP1260220B1 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these |
| 12/02/2009 | CN101595133A Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| 12/02/2009 | CN101594891A Film-forming gel composition for wound or skin care |
| 12/02/2009 | CN101594875A Methods and formulations for improved bioavalability of antiprogestins |
| 12/02/2009 | CN101594873A Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue |
| 12/02/2009 | CN101594865A Pharmaceutical composition containing low-substituted hydroxypropylcellulose |
| 12/02/2009 | CN101594864A Method for producing solid preparation |
| 12/02/2009 | CN101594863A Film-coated preparation having improved stability |
| 12/02/2009 | CN101594854A Polynuclear microcapsules |
| 12/02/2009 | CN101594853A Modified release ibuprofen solid oral dosage form |
| 12/02/2009 | CN101594852A Melt-processed imatinib dosage form |
| 12/02/2009 | CN101594851A Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 12/02/2009 | CN101594850A Antilipidemic pharmaceutical compositions and process for preparation thereof |
| 12/02/2009 | CN101594849A Matrix-embedded compositions having organic acids and fatty acids |
| 12/02/2009 | CN101594848A Granulate containing a pharmaceutically active substance and method for its manufacture |
| 12/02/2009 | CN101591666A Preparation for pCN-SSISG of dual-promoter bivalent anti-caries DNA vaccine |
| 12/02/2009 | CN101591235A Method for producing low lead granular magnesium citrate |
| 12/02/2009 | CN101591234A Method for producing magnesium citrate |
| 12/02/2009 | CN101590291A Gel composition for medical material or hygiene material, molded article thereof and adhesive material or adhesive preparation using same |
| 12/02/2009 | CN101590241A Cisplatin nano-micelle prodrug and preparation method thereof |
| 12/02/2009 | CN101590236A Composition containing calcium antagonist and Statins and application thereof |
| 12/02/2009 | CN101590230A Pharmaceutical composition containing renin inhibitor, diuretic agent and folic acid and application thereof |
| 12/02/2009 | CN101590227A Vaccine product with respectively packaged freeze-dried vaccine and dilute solution thereof and method for preparing dilute solution |
| 12/02/2009 | CN101590223A SOD complex capsule and preparation method thereof |
| 12/02/2009 | CN101590222A SOD cell repair liquid and preparation method thereof |
| 12/02/2009 | CN101590220A Method for preparing interferon liposome injection |
| 12/02/2009 | CN101590214A Ear patch for reducing weight |
| 12/02/2009 | CN101590213A Chinese medicinal decoction for treating lithiasis and preparation method thereof |
| 12/02/2009 | CN101590200A Application of traditional Chinese medicine composition in preparing medicament for treating tumors |
| 12/02/2009 | CN101590193A Traditional Chinese medicine combination for treating leukemia and preparation method thereof |
| 12/02/2009 | CN101590192A Traditional Chinese medicine combination for treating leukemia and preparation method thereof |
| 12/02/2009 | CN101590190A Traditional Chinese medicine composition for treating toxuria |
| 12/02/2009 | CN101590189A Traditional Chinese medicine composition containing radix aconiti carmichaeli for treating myasthenia gravis and preparation thereof |
| 12/02/2009 | CN101590187A Chinese medicinal capsule for treating prosopantritis, ethmoiditis and genyantritis |
| 12/02/2009 | CN101590185A Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof |
| 12/02/2009 | CN101590184A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590183A Application of medicinal composition in preparing medicaments for treating fracture |
| 12/02/2009 | CN101590182A Application of traditional Chinese medicine composition in preparing medicine for reducing malignant cytokine level |
| 12/02/2009 | CN101590181A Application of traditional Chinese medicine composition in preparing medicine for improving cytokine expression |
| 12/02/2009 | CN101590180A Application of traditional Chinese medicine composition in preparing medicine for inhibiting cardiac muscle cell apoptosis |
| 12/02/2009 | CN101590178A Application of traditional Chinese medicine composition in preparation of medicine for treating refractory premature beat of elderly patient |
| 12/02/2009 | CN101590177A Chinese medicinal herb mixture for treating AIDS and preparation method thereof |
| 12/02/2009 | CN101590169A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590168A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590167A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590166A Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 12/02/2009 | CN101590164A Traditional Chinese medicine composition containing radix astragalus for treating myasthenia gravis and preparation thereof |
| 12/02/2009 | CN101590163A Medicament for treating dementia and preparation method thereof |
| 12/02/2009 | CN101590162A Yidanshu slow-release tablet for treating pancreatitis or cholecystitis and preparation method thereof |
| 12/02/2009 | CN101590156A Patch for treating miocardial infarction and manufacturing method |
| 12/02/2009 | CN101590155A Patch for treating miocardial infarction |
| 12/02/2009 | CN101590154A Antioxidant health care soft capsule |
| 12/02/2009 | CN101590152A Preparation method of Bawei Chenxiang capsule |
| 12/02/2009 | CN101590149A Traditional Chinese medicine composition with function of relieving asthenopia and preparation method thereof |
| 12/02/2009 | CN101590148A Chewing gum for preventing common cold |
| 12/02/2009 | CN101590147A Chinese medicinal composition for treating cervical and lumbar diseases and preparation method thereof |